Bindarit is an anti-inflammatory agent that inhibits MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8 synthesis [10], acting through the down-regulation of NF-kB pathway [11], that shows potent anti-inflammatory activity in animal models of both acute and chronic inflammation [12]–[15]. Here, CCL2 is linked to inflammation.